Huamei Haolian Secures Nearly RMB 100 Million in Series C Funding to Advance AI-Powered Integrated Digital Healthcare Services Across Medical, Pharmaceutical, and Insurance Sectors

E-Health Now Secures Funding—Again.

Since announcing its Series A financing in 2021, E-Health Now has basically maintained a pace of one funding round per year, with each round raising tens of millions. Just asE-Health Now Officially Announces Completion of Series C FinancingRecently, E-Health Now officially announced the completion of its Series C financing round. Investors in this round included Ameba Capital, Ventech China, and Borchid Capital, among others, with the total amount raised reaching nearly RMB 100 million.The funds raised in this round of financing will be primarily used for the research and development of services and products, marketing and promotion, as well as advancing the upgrade and construction of an AI-driven digital healthcare service platform.

In 2022, E-Health Now officially positioned itself as a “one-stop AI-driven digital healthcare service platform,” and successively launched multiple AI-powered products, including Dr. Hua AI General Practitioner and Dr. Hua AI Precision Healthcare Access, thereby continuously strengthening its strategic footprint in the artificial intelligence sector.

To date, E-Health Now has provided AI-driven digital healthcare services to over 30 million end users. Leveraging its AI-based digital technologies, the company has established business partnerships with nearly 100 medium-to-large insurance institutions in China, as well as approximately 80 banks and enterprises.

Frankly speaking, at a time when all sectors of the industry have high expectations for AI-driven digital technologies, few companies are truly able to maximize their potential. So how has E-Health Now efficiently leveraged AI technology to achieve remarkable business results while continuously securing capital support? And how will E-Health Now continue to advance the development of its “one-stop AI-powered digital healthcare service platform” in the future? In light of the completion of this round of financing, VCBeat conducted an in-depth interview with Xu Bingyu, Founder and CEO of E-Health Now, to seek answers.

The core reason why E-Health Now has maximized the utility of AI-driven digital technologies in the fields of health insurance and health management lies in its profound understanding of customers’ genuine needs for digital solutions, rather than pursuing “digitalization for the sake of digitalization.”

Given thatAt this stage, E-Health Now’s business model is “to provide insurance and financial institutions with four major solutions—customer acquisition, value-added services, risk control, and health insurance product innovation—through the integration and technological empowerment of high-quality medical resources both domestically and internationally, operating under a B2B2C model, while providing enterprises with employee health management and welfare services.”Therefore, E-Health Now’s primary clients are insurance institutions, banks, and enterprises; its business framework can be broadly categorized into two segments: health management services and innovation enablement for health insurance products.

Let us first examine the health management services business. This is the “foundation” of E-Health Now.

To date, the development of health management services in China has been characterized by intense competition focused on the accumulation of service resources. E-Health Now is no exception. Since its official establishment in September 2017, E-Health Now has established collaborative relationships with seven renowned international healthcare systems, 41 medical specialties, and over 2,000 international experts. It has officially contracted with more than 230 high-quality Grade A tertiary hospitals in China, and its medical service network covers 1,312 Grade A tertiary hospitals nationwide, weaving a rich and comprehensive medical resource network.

After comprehensively considering multiple factors, including the maturity of internal technology applications, the potential application of external new technologies, and market demand, E-Health Now officially announced its strategic upgrade in 2022, positioning itself as a “One-Stop AI-Driven Digital Healthcare Service Platform.”

So, what exactly is E-Health Now’s path in applying AI-driven digital technologies to healthcare services?

According to E-Health Now, the application of AI-driven digital technologies in the health management and healthcare sectors primarily encompasses five areas: first, health data monitoring and analysis; second, intelligent assisted diagnosis; third, personalized health guidance; fourth, chronic disease management; and fifth, resource allocation and optimization.

By organizing and summarizing the five aforementioned application directions, we can see thatCurrently, the application of artificial intelligence and digital technologies in health management services primarily encompasses three major scenarios: first, providing personalized health management for individuals with chronic diseases and those seeking general health management, based on health data monitoring and analysis; second, intelligent assisted diagnosis with more pronounced medical attributes; and third, the rational allocation of healthcare resources.

Specifically, in terms of E-Health Now’s exploratory practices, with regard to personalized health management,For Healthy Individuals,Upon obtaining user authorization, E-Health Now will first collect and analyze health data, such as physiological parameters and medical records, via its “AI-Driven Digital Healthcare Service Platform,” and then provide personalized health guidance, including dietary recommendations, exercise plans, and disease prevention strategies.

For the health management needs of patients with chronic diseases,E-Health Now not only monitors patients’ health data in real time, providing timely alerts for abnormalities and corresponding interventions, but also delivers scientific and professional follow-up services to improve patients’ compliance with follow-up visits and medication regimens.

Meanwhile,To address the widespread issues in the health checkup market, such as the lack of post-examination report interpretation and the absence of post-examination management services, E-Health Now has launched the “Dr. Hua AI Health Checkup Analysis” service,It can rapidly interpret health checkup reports and provide users with personalized health guidance, including dietary recommendations and exercise plans. Additionally, based on the analysis of these reports, E-Health Now helps users promptly identify potential health risks and offers medical consultation advice when abnormalities are detected in their checkup results.

In terms of “Medical Consultation Recommendations,”E-Health Now has achieved auxiliary diagnosis and the rational allocation of medical and health resources. VCBeat learned thatIn 2023, E-Health Now launched “Dr. Hua AI Precision Healthcare,” a system featuring three core capabilities: first, it provides on-demand responses to user health inquiries; second, it rapidly analyzes user symptoms to recommend the most appropriate hospitals, departments, and physicians, thereby preventing indiscriminate medical visits and improving healthcare efficiency; and third, through precise triage, it reduces unnecessary medical tests and medication use, thus lowering healthcare costs.

In other words, “Huayisheng AI Precision Healthcare” focuses on “precise matching” between patients and doctors, thereby facilitating the rational allocation of medical resources. Admittedly, prior to achieving this “precise matching,” the platform analyzes users’ health status and corresponding symptoms, thus fulfilling a certain “auxiliary diagnostic” function.

Furthermore, in its efforts to enhance the efficiency of medical services, E-Health Now has launched the “Hua Doctor AI Assistant” for physicians. This tool can identify and document doctor-patient consultations in real time, providing features such as consultation prompts and medication safety alerts. As a result, while improving physicians’ workflow efficiency, it also enhances patients’ access to care and clinical experience to a certain extent, thereby accelerating the digital transformation of hospitals.

Meanwhile, E-Health Now has also launched “Dr. Hua AI General Practitioner” for end users. By integrating extensive medical knowledge with E-Health Now’s proprietary business data to develop its own large language model, and combining artificial intelligence technologies with the expertise of professional medical teams, the platform delivers intelligent health management services. It provides robust support for both individuals and insurance companies in medical decision-making and health management.

Let’s take another look at E-Health Now’s health insurance-related business.

In May this year, Xu Bingyu, Founder and CEO of E-Health Now, publicly stated that,In the health insurance and health management sector, artificial intelligence and digital technologies present three major opportunities: first, they can enhance the precision of integrating health management with health insurance; second, they can expand the reach of health management and health insurance service providers; and third, they can drive innovation in health management and health insurance products.

The combination of these three points precisely aligns with the four major solutions that E-Health Now provides to financial institutions—customer acquisition, value-added services, risk control, and health insurance product innovation—and essentially covers the entire chain of health insurance product development and operations.

First,In terms of innovative product development in health insurance,Leveraging AI-driven digital technologies, E-Health Now assists insurance companies in developing innovative health insurance products tailored to user needs and evolving market trends. With the support of intelligent risk control technologies, the health insurance market can further expand. The growing exploration of non-standard risk health insurance by major insurers in recent years serves as a prime example.

In the risk control phase,By retrieving customer health data from databases, E-Health Now enables insurers to more accurately assess individual health status and risk levels, rapidly identify high-risk customers, improve insurance underwriting efficiency, and reduce claim costs by controlling expenditures across every stage of medical care.

Taking the “No-Medical-Exam Million-Yuan Medical Insurance for Middle-Aged and Elderly Adults,” a product jointly launched by E-Health Now and an insurance company, as an example, E-Health Now leverages AI-powered underwriting to transform the traditional requirement of “mandatory medical examinations for elderly applicants” into a streamlined process where customers need only submit medical records and health checkup reports. The AI underwriting backend then performs risk extraction and assessment, thereby reducing marketing costs and enhancing risk management capabilities.

In terms of customer acquisition and value-added services,E-Health Now’s universal health management services can serve as innovative insurance marketing tools—such as health cards, assessment questionnaires, and mini-programs—covering multiple scenarios including expert lectures, live-streamed promotions, and offline sales events, thereby empowering insurance companies in marketing and customer acquisition.

Meanwhile, leveraging its integrated online-to-offline portfolio of over 70 health service products, E-Health Now not only helps insurers customize innovative health insurance products—thereby enhancing their appeal to a certain extent—but also further assists insurers in strengthening their risk management capabilities through a combined approach of health monitoring and health intervention.

In this way, by leveraging the integrated application of a series of artificial intelligence technologies and healthcare services, E-Health Now can not only assist insurance companies in developing health insurance products that better meet market demands, thereby indirectly expanding the health insurance market, but also help insurers enhance risk control capabilities and improve underwriting and claims settlement efficiency through intelligent tools and health management services. Furthermore, by aggregating and rationally utilizing medical resources empowered by digital technology, E-Health Now can increase the value of health insurance products, thereby further enhancing their appeal.

From enhancing the efficiency of health management services to precisely matching medical resources, from health consultations to personalized health management guidance, and from the innovative development of health insurance products to assisting in underwriting and claims processing, as well as improving risk control capabilities, E-Health Now has precisely applied the “powerful tool” of artificial intelligence to every link where it is needed.

Yet, the story of E-Health Now’s AI-driven digital technology applications and their integrated development with health insurance and health management continues.

“What will be the future development trends of the industry?” Before introducing E-Health Now’s future development plans, Xu Bingyu first addressed this question for VCBeat.

“Looking ahead, as technology continues to advance and application scenarios expand, AI will bring more innovation and transformation to the fields of health management and health insurance,” summarized Xu Bingyu.

Specifically, first, the application of technologies such as deep learning and natural language processing will further enhance the analysis and prediction capabilities for health data; second, AI technology can provide users with more personalized health management solutions, and intelligent services such as smart triage and automated underwriting and claims processing will become future development trends; third, with the further development of health management and health insurance, cross-industry collaboration among medical institutions, insurance companies, and technology firms will accelerate the application and promotion of AI technology; fourth, user experience and service quality will serve as key metrics for evaluating the application of AI technology in the fields of health management and health insurance. Therefore, the industry will place greater emphasis on improving user experience and service quality to meet users’ growing demands.

On this basis,E-Health Now will continue to increase its R&D investment in cutting-edge technologies such as artificial intelligence and big data, constantly optimize and upgrade its one-stop AI-driven digital healthcare service platform, improve its digital health management service system, and deepen cooperation with medical institutions, financial institutions, technology companies, and especially insurance carriers, aiming to develop more health insurance products that meet user needs and provide users with more comprehensive health protection. Meanwhile, E-Health Now will also actively explore overseas markets to enhance its international influence.

We look forward to seeing the future of E-Health Now’s integrated development with AI-driven digital health insurance and health management services.

Lead Investor: Bai Jieyong, Ameba CapitalStatement: E-Health Now is a leading enterprise in the application of large AI models within the healthcare industry. It stands as an outstanding representative of new quality productive forces amidst the revolutionary breakthroughs of this round of AI technology and the profound upgrading of healthcare services. The company has established a comprehensive system covering pre-diagnosis, intra-diagnosis, and post-diagnosis phases, and has integrated and connected resources across multiple sectors—including insurance, hospitals, pharmaceutical manufacturers, medical device companies, and industrial clients—throughout the industry’s AI-driven digital transformation. Currently, E-Health Now operates under a dual-drive strategy of AI technological innovation and high-quality medical services, entering a phase of rapid growth. We are honored to lead this round of financing and firmly believe that the company will continue to innovate, leveraging its superior and advanced productive capabilities to provide more equitable and efficient healthcare services to people across China.

Co-investor: Ventech ChinaStatement: We are delighted to see that E-Health Now has solidified its business foundation while actively embracing artificial intelligence over the past few years, achieving remarkable results. The positive market response to its intelligent medical platform and digital health management solutions reinforces our confidence in a broader development blueprint for the company’s future.

Chang Xin, Borchid Capital (Co-investor)Statement: As an AI-driven digital healthcare services provider, E-Health Now has demonstrated exceptional innovation and market influence against the backdrop of rapid growth in China’s health insurance and health management sectors. The company has accumulated substantial resources within the medical industry and established extensive partnerships with numerous insurance and financial institutions. Following its participation in the previous funding round, Borchid Capital has witnessed the company’s rapid expansion and highly recognizes the capabilities of its founders and founding team. We believe in and look forward to the company’s continued leverage of its technological innovation advantages to lead industry progress, drive the high-speed development of China’s health insurance and health management sectors, and ultimately benefit the health of the Chinese people.

E-Health Now, established in 2017, is a one-stop AI-driven digital healthcare service platform. By integrating high-quality medical resources and leveraging technological empowerment, it adopts a B2B2C model to comprehensively empower insurance institutions, banks, enterprises, and healthcare providers. The platform delivers high-quality healthcare services covering the entire lifecycle—pre-diagnosis, during diagnosis, and post-diagnosis—with the aim of helping hundreds of millions of Chinese families achieve health and well-being.

Ameba Capital, established in 2011, focuses on China’s next-generation information technology industry, with a particular emphasis on new quality productive forces. Adopting a data-driven approach, it selects intelligent sub-sectors characterized by large-scale scenarios, high barriers to entry, cross-cycle resilience, and compounding effects. The firm is dedicated to identifying entrepreneurs with strong survival and adaptability capabilities, as well as rapid execution skills. To date, Ameba Capital has invested in hundreds of startups across early and growth stages, including Didi Kuaidi, Mogujie, Nanomicro Tech, Yaoyao Medicine, Jushuitan, Leyan Technology, Xiaoyang Education, and Baiying.

Ventech China, also known as Yintai Capital, has long been committed to investing in early-stage projects within the broad consumer sector. It excels at identifying companies with unicorn potential at an early stage and has successfully invested in enterprises such as Jumei Youpin, Keep, Wandou Gongzhu, Blued, Xianmu, Supermonkey, and Asia Innovations.

Borchid Capital, established in 2018, is a boutique venture capital firm specializing in early-to-growth stage investments in new consumption and the application of core TMT technologies. Dedicated to investing in visions for a better life, it strives to be a precise discoverer of early-stage value and a significant long-term partner for entrepreneurs. The core founders of Borchid Capital hail from top-tier venture capital firms both domestically and internationally, boasting over a decade of investment experience and a successful track record of investing in numerous listed companies in China and abroad.